Research On Motivation And Performance Of China Resources Sanjiu Continuous Mergers And Acquisitions

With the growth of China’s financial sector in recent years as an important part of China’s economy,the medical industry has reached rapid expansion into the industry.combination and medicine prices can lead to an increase in the number of ingredients in the medical market and the purchase of medicines.However,not all M&A practices can increase the profitability of the business,and some M&A business practices increase sales costs and create a financial crisis.By choosing a business that supports the goal of mergers and acquisitions,and combining mergers and acquisitions with good post-M&A service,companies can redistribute their internal products and company profits.In this article,CR Sanjiu was chosen as the research sample and ongoing M&A transactions from 2008 to 2020 to examine the motivation and performance of CR Sanjiu’s continuous M&A activities.The first chapter shows the background of the research and importance of this book and introduces the research literature on dynamic,the performance and related performance analysis from constant mergers and successes and finally represent the research methods and research materials used in this paper.Chapter 2 describes the relevant conceptsand overviews of continuous M&A and M&A work is underway and provides the necessary support to take into account the analysis of the following points.Chapter 3presents the cases,first presenting the development and M&A status of the entire pharmaceutical industry and then summarizing the current situation and the continuous M&A process CR Sanjiu.And detailed analysis of ongoing enthusiasm for the combined and acins of CR Sanjiu,combined with corporate strategy.The fourth section is dedicated to the analysis of continuous indicators M&A CR Sanjiu,the analysis of its short-and long-term market indicators using the method of event research and the method of financial India,and an additional analysis using the method of economic added value.Chapter 5 is Conclusion and Enlightenment: Related to the Upcoming Benefits and Challenges of CR Sanjiu in Continuous Mergers and Acquisitions Completed,and accordingly,the M&A hole is shown to provide evidence of constant mergers and acquisitions in the pharmaceutical industry.The research results show that M&A measures are always oriented towards the strategic goals of the companies and that the search for suitable M&A targets according to their own needs not only increases their basic competitiveness,but also strengthens their market position.At the same time,however,there are some problems in the M&A process.The continuous payment of cash during M&A leads to an increase in financial risks,and existing marketing channels and marketing benefits of the acquired resources are not optimized according to M&A.Building on this,this paper proposes that in the future,the M&A process: First,it is necessary to screen suitable M&A targets and reasonably assess the value of the target enterprise;Second,it is necessary to adjust the M&A strategy in a timely manner and strengthen the post-merger integration;Third,we must choose diversified M&A payment methods.